Cytodyn Inc To Host Investor Community Conference Call Transcript
Hello, everyone, and thank you for joining us today. This is Michael Mulholland, Chief Financial Officer of CytoDyn. Joining us on today's call is our President and CEO, Dr. Nader Pourhassan; and our Chairman, Chief Medical Officer and Head of Business Development, Dr. Scott Kelly.
Before we begin, it is essential that we provide you with important cautionary language related to certain federal securities laws. Our remarks during today's conference call will include forward-looking statements. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are difficult to predict. Actual results may be materially different from any future results expressed or implied by such forward-looking statements.
These risks and uncertainties include, among other matters, statements regarding Leronlimab potential efficacy in certain immunology and oncology indications, the company's ongoing ability to raise additional new capital that clinical trials may not commence or proceed as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
